1. Home
  2. FOXO vs POAI Comparison

FOXO vs POAI Comparison

Compare FOXO & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXO
  • POAI
  • Stock Information
  • Founded
  • FOXO 2019
  • POAI 2002
  • Country
  • FOXO United States
  • POAI United States
  • Employees
  • FOXO N/A
  • POAI N/A
  • Industry
  • FOXO Retail: Computer Software & Peripheral Equipment
  • POAI Industrial Specialties
  • Sector
  • FOXO Technology
  • POAI Health Care
  • Exchange
  • FOXO Nasdaq
  • POAI Nasdaq
  • Market Cap
  • FOXO 4.9M
  • POAI 9.7M
  • IPO Year
  • FOXO N/A
  • POAI N/A
  • Fundamental
  • Price
  • FOXO $0.24
  • POAI $1.62
  • Analyst Decision
  • FOXO
  • POAI Hold
  • Analyst Count
  • FOXO 0
  • POAI 1
  • Target Price
  • FOXO N/A
  • POAI N/A
  • AVG Volume (30 Days)
  • FOXO 13.7M
  • POAI 2.8M
  • Earning Date
  • FOXO 11-19-2024
  • POAI 03-27-2025
  • Dividend Yield
  • FOXO N/A
  • POAI N/A
  • EPS Growth
  • FOXO N/A
  • POAI N/A
  • EPS
  • FOXO N/A
  • POAI N/A
  • Revenue
  • FOXO $1,341,000.00
  • POAI $1,484,223.00
  • Revenue This Year
  • FOXO N/A
  • POAI N/A
  • Revenue Next Year
  • FOXO N/A
  • POAI $569.48
  • P/E Ratio
  • FOXO N/A
  • POAI N/A
  • Revenue Growth
  • FOXO 196.03
  • POAI N/A
  • 52 Week Low
  • FOXO $0.13
  • POAI $0.55
  • 52 Week High
  • FOXO $1.30
  • POAI $3.76
  • Technical
  • Relative Strength Index (RSI)
  • FOXO 46.29
  • POAI 62.46
  • Support Level
  • FOXO $0.20
  • POAI $1.37
  • Resistance Level
  • FOXO $0.23
  • POAI $1.58
  • Average True Range (ATR)
  • FOXO 0.02
  • POAI 0.13
  • MACD
  • FOXO 0.00
  • POAI -0.01
  • Stochastic Oscillator
  • FOXO 52.70
  • POAI 93.55

About FOXO FOXO Technologies Inc.

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Share on Social Networks: